{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:58:19Z","timestamp":1794005899459,"version":"4.8.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100015752","name":"British Columbia Lung Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015752","name":"British Columbia Lung Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015752","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>High costs of controller therapies may be a barrier to guideline-recommended asthma treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We determined whether eliminating out-of-pocket (OOP) payments among low-income patients with asthma impacted controller medication use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We applied a controlled interrupted time series design to administrative claims data in British Columbia, Canada from 2017 to 2020. Cases were individuals with an annual household income &amp;lt;$13,750 in whom copays were eliminated in January 2019; there was no change in public coverage for the control group with annual income &amp;gt;$45,000. We evaluated trends in asthma medication costs, use, the ratio of inhaled corticosteroid-containing medications to all asthma medications, excessive use of short-acting \u03b2-agonists (more than one canister per month), and the proportion of days covered by controller therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 12,940 cases (62% female; mean age, 30.3 yr; standard deviation [SD], 14.9) and 71,331 controls (55% female; mean age, 31.3 yr; SD, 16.3). Removal of OOP payments increased monthly mean medication costs by $3.32 (95% confidence interval [CI], $0.08 to $6.56, 2020 Canadian dollars), days\u2019 supply of controller medications by 1.50 days (95% CI, 0.61 to 2.40 d), and the ratio of inhaled corticosteroid-containing medications to total medications by 4.20% (95% CI, 0.73% to 7.66%) compared with the control group. The policy had no effect on the proportion of days covered by controller therapies (0.01; 95% CI, \u22120.01 to 0.04), but nonsignificantly decreased the percentage of patients with excessive short-acting \u03b2-agonist use (\u22126.37%; 95% CI, \u221212.90% to 0.16%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Removal of OOP payments increased the dispensation of controller therapies, suggesting cost-related nonadherence could impair optimal asthma management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202402-130oc","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T17:29:51Z","timestamp":1722965391000},"page":"1542-1549","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":4,"title":["The Impact of Eliminating Out-of-Pocket Payments on Asthma Medication Use"],"prefix":"10.1093","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7406-2448","authenticated-orcid":false,"given":"Kate M.","family":"Johnson","sequence":"first","affiliation":[{"name":"Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences"},{"name":"Division of Respiratory Medicine, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Cheng","sequence":"additional","affiliation":[{"name":"Centre for Health Services and Policy Research, School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Yin","sequence":"additional","affiliation":[{"name":"Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Carter","sequence":"additional","affiliation":[{"name":"Patient Partner, Legacy for Airway Health Community Partner Committee, Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santa","family":"Chow","sequence":"additional","affiliation":[{"name":"Patient Partner, Legacy for Airway Health Community Partner Committee, Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Brigham","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Law","sequence":"additional","affiliation":[{"name":"Centre for Health Services and Policy Research, School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"2026012203190902800_bib1","article-title":"Global strategy for asthma management and prevention","author":"Global Initiative for Asthma","year":"2023"},{"key":"2026012203190902800_bib2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S2213-2600(20)30105-3","article-title":"Prevalence and attributable health burden of chronic respiratory diseases, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"8","author":"Soriano","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026012203190902800_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.rmed.2018.03.018","article-title":"The projected economic and health burden of sub-optimal asthma control in Canada","volume":"138","author":"Zafari","year":"2018","journal-title":"Respir Med"},{"key":"2026012203190902800_bib4","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1001\/jama.2012.340","article-title":"Out-of-pocket medication costs and use of medications and health care services among children with asthma","volume":"307","author":"Karaca-Mandic","year":"2012","journal-title":"JAMA"},{"key":"2026012203190902800_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1001\/archpediatrics.2007.21","article-title":"Effect of cost-sharing on use of asthma medication in children","volume":"162","author":"Ungar","year":"2008","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2026012203190902800_bib6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.healthpol.2020.05.001","article-title":"What happens to drug use and expenditure when cost sharing is completely removed? Evidence from a Canadian provincial public drug plan","volume":"124","author":"Laba","year":"2020","journal-title":"Health Policy"},{"key":"2026012203190902800_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/jamainternmed.2019.4472","article-title":"Effect on treatment adherence of distributing essential medicines at no charge: the CLEAN Meds randomized clinical trial","volume":"180","author":"Persaud","year":"2019","journal-title":"JAMA Intern Med"},{"key":"2026012203190902800_bib8","doi-asserted-by":"crossref","first-page":"e1003590","DOI":"10.1371\/journal.pmed.1003590","article-title":"Adherence at 2 years with distribution of essential medicines at no charge: the CLEAN Meds randomized clinical trial","volume":"18","author":"Persaud","year":"2021","journal-title":"PLoS Med"},{"key":"2026012203190902800_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.37765\/ajmc.2021.88664","article-title":"Association of co-pay elimination with medication adherence and total cost","volume":"27","author":"Cong","year":"2021","journal-title":"Am J Manag Care"},{"key":"2026012203190902800_bib10","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1056\/NEJMsa1107913","article-title":"Full coverage for preventive medications after myocardial infarction","volume":"365","author":"Choudhry","year":"2011","journal-title":"N Engl J Med"},{"key":"2026012203190902800_bib11","year":"2020"},{"key":"2026012203190902800_bib12","article-title":"Census profile, 2021 census of population: British Columbia","author":"Statistics Canada","year":"2022"},{"key":"2026012203190902800_bib13","volume-title":"Inventory of studies on the accuracy of Canadian Health Administrative Databases","author":"Williams","year":"1996"},{"key":"2026012203190902800_bib14","article-title":"PharmaCare","author":"British Columbia Ministry of Health","year":"2011"},{"key":"2026012203190902800_bib15","article-title":"Vital events births","author":"British Columbia Ministry of Health","year":"2011"},{"key":"2026012203190902800_bib16","article-title":"Vital events deaths","author":"British Columbia Ministry of Health","year":"2011"},{"key":"2026012203190902800_bib17","article-title":"Consolidation file (MSP Registration & Premium Billing)","author":"British Columbia Ministry of Health","year":"2011"},{"key":"2026012203190902800_bib18","article-title":"Discharge abstract database (hospital separations)","author":"Canadian Institute for Health Information","year":"2011"},{"key":"2026012203190902800_bib19","article-title":"Medical Services Plan (MSP) payment information file","author":"British Columbia Ministry of Health","year":"2011"},{"key":"2026012203190902800_bib20","doi-asserted-by":"crossref","first-page":"E167","DOI":"10.9778\/cmajo.20180198","article-title":"Impact of a household-level deductible on prescription drug use among lower-income adults: a quasi-experimental study","volume":"7","author":"Law","year":"2019","journal-title":"CMAJ Open"},{"key":"2026012203190902800_bib21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1475-6773.2007.00775.x","article-title":"Identifying persons with treated asthma using administrative data via latent class modelling","volume":"43","author":"Prosser","year":"2008","journal-title":"Health Serv Res"},{"key":"2026012203190902800_bib22","first-page":"183","article-title":"Identifying patients with physician-diagnosed asthma in health administrative databases","volume":"16","author":"Gershon","year":"2009","journal-title":"Can Respir J"},{"key":"2026012203190902800_bib23","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/thoraxjnl-2019-213223","article-title":"Economic burden of multimorbidity in patients with severe asthma: a 20-year population-based study","volume":"74","author":"Chen","year":"2019","journal-title":"Thorax"},{"key":"2026012203190902800_bib24","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.chest.2016.10.028","article-title":"Has asthma medication use caught up with the evidence? A 12-year population-based study of trends","volume":"151","author":"Sadatsafavi","year":"2017","journal-title":"Chest"},{"key":"2026012203190902800_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12931-021-01696-x","article-title":"Trends in oral corticosteroids use in severe asthma: a 14-year population-based study","volume":"22","author":"Sadatsafavi","year":"2021","journal-title":"Respir Res"},{"key":"2026012203190902800_bib26","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jaip.2016.12.023","article-title":"Burden of chronic oral corticosteroid use by adults with persistent asthma","volume":"5","author":"Zeiger","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026012203190902800_bib27","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1183\/09031936.00100113","article-title":"Asthma drug ratios and exacerbations: claims data from universal health coverage systems","volume":"43","author":"Laforest","year":"2014","journal-title":"Eur Respir J"},{"key":"2026012203190902800_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12875-015-0265-2","article-title":"Prescribed therapy for asthma: therapeutic ratios and outcomes","volume":"16","author":"Laforest","year":"2015","journal-title":"BMC Fam Pract"},{"key":"2026012203190902800_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12890-018-0598-4","article-title":"Predictors of inappropriate and excessive use of reliever medications in asthma: a 16-year population-based study","volume":"18","author":"Tavakoli","year":"2018","journal-title":"BMC Pulm Med"},{"key":"2026012203190902800_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jclinepi.2008.08.007","article-title":"Methods for estimating confidence intervals in interrupted time series analyses of health interventions","volume":"62","author":"Zhang","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"2026012203190902800_bib31","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJM200008033430504","article-title":"Low-dose inhaled corticosteroids and the prevention of death from asthma","volume":"343","author":"Suissa","year":"2000","journal-title":"N Engl J Med"},{"key":"2026012203190902800_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.anai.2010.10.006","article-title":"Relationship of asthma management, socioeconomic status, and medication insurance characteristics to exacerbation frequency in children with asthma","volume":"106","author":"Ungar","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026012203190902800_bib33","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/thorax.57.10.880","article-title":"Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma","volume":"57","author":"Suissa","year":"2002","journal-title":"Thorax"},{"key":"2026012203190902800_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.anai.2023.10.017","article-title":"Impact of income-based public drug coverage deductibles on adherence to asthma medications","volume":"132","author":"Johnson","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026012203190902800_bib35","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.2018.2769","article-title":"Association of inhaled corticosteroids and long-acting \u03b2-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis","volume":"319","author":"Sobieraj","year":"2018","journal-title":"JAMA"},{"key":"2026012203190902800_bib36","first-page":"CD007313","article-title":"Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children","volume":"2013","author":"Cates","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2026012203190902800_bib37","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.jaip.2021.10.011","article-title":"A practical guide to implementing SMART in asthma management","volume":"10","author":"Reddel","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026012203190902800_bib38","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s43441-021-00372-y","article-title":"Medication cost-savings and utilization of generic inhaled corticosteroid (ICS) and long-acting beta-agonist (LABA) drug products in the USA","volume":"56","author":"Wang","year":"2022","journal-title":"Ther Innov Regul Sci"},{"key":"2026012203190902800_bib39","doi-asserted-by":"crossref","first-page":"E63","DOI":"10.9778\/cmajo.20180008","article-title":"The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey","volume":"6","author":"Law","year":"2018","journal-title":"CMAJ Open"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/21\/11\/1542\/66013988\/annalsats_21_11_1542.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/21\/11\/1542\/66013988\/annalsats_21_11_1542.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:19:14Z","timestamp":1769069954000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/21\/11\/1542\/8380747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,1]]},"published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202402-130oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,11,1]]},"assertion":[{"value":"2024-02-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}